Literature DB >> 15516345

Minimum effective local anaesthetic dose of isobaric levobupivacaine and ropivacaine administered via a spinal catheter for hip replacement surgery.

A Sell1, K T Olkkola, J Jalonen, R Aantaa.   

Abstract

BACKGROUND: Continuous spinal anaesthesia with spinal catheters allows incremental dosing of local anaesthetic and, consequently, less haemodynamic changes. However, little is known about the required doses. Therefore, we designed a study to assess the minimum effective local anaesthetic dose (MLAD) of levobupivacaine and ropivacaine in this context.
METHODS: Forty-one patients undergoing hip replacement surgery were randomly allocated to one of the two local anaesthetic groups in a double-blind manner. The initial dose of local anaesthetic was determined by the response of the previous patient: the effective dose resulted in a 1 mg decrease in the dose of levobupivacaine or ropivacaine, and an ineffective dose resulted in a 1 mg increase. The MLAD was calculated by the Dixon up-and-down method.
RESULTS: The MLAD of levobupivacaine was 11.7 mg (95% CI, 11.1-12.4) and that of ropivacaine 12.8 mg (95% CI, 12.2-13.4).
CONCLUSIONS: These doses are significantly smaller than doses reported before for single-shot spinal anaesthesia. Continuous spinal anaesthesia allows the use of relatively small doses of local anaesthetic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516345     DOI: 10.1093/bja/aei015

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  12 in total

Review 1.  [Levobupivacaine for regional anesthesia. A systematic review].

Authors:  B Urbanek; S Kapral
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

2.  Low-dose ropivacaine or levobupivacaine walking spinal anesthesia in ambulatory inguinal herniorrhaphy.

Authors:  Vildan Taspinar; Altan Sahin; Nezihe F Donmez; Yasar Pala; Aydin Selcuk; Murat Ozcan; Bayazit Dikmen
Journal:  J Anesth       Date:  2011-01-12       Impact factor: 2.078

3.  Minimum local anesthetic dose of ropivacaine in real-time ultrasound-guided intraspinal anesthesia for lower extremity surgery: a randomized controlled trial.

Authors:  Ting Zheng; Peng Ye; Weilan Wu; Bin Hu; Lifei Chen; Xiaochun Zheng; Mingxue Lin
Journal:  Ann Transl Med       Date:  2020-07

4.  Continuous Spinal Anaesthesia for Endovascular Repair of Abdominal Aortic Aneurysm in High-Risk Patient.

Authors:  Kadir Özyılmaz; Özgür Yağan; Nilay Taş; Volkan Hancı
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-02-05

Review 5.  Clinical Pharmacokinetics and Pharmacodynamics of Levobupivacaine.

Authors:  Chantal A A Heppolette; Derek Brunnen; Sohail Bampoe; Peter M Odor
Journal:  Clin Pharmacokinet       Date:  2020-06       Impact factor: 6.447

6.  Effect of intravenous phenylephrine infusion on dose requirement of intrathecal plain levobupivacaine for cesarean section: A placebo-controlled preliminary study.

Authors:  Asha Tyagi; Aanchal Kakkar; Namrata Niwal; Medha Mohta; Ashok Kumar Sethi
Journal:  Saudi J Anaesth       Date:  2017 Oct-Dec

7.  Update on local anesthetics: focus on levobupivacaine.

Authors:  Crina L Burlacu; Donal J Buggy
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

8.  Clinical profile of levobupivacaine in regional anesthesia: A systematic review.

Authors:  Sukhminder Jit Singh Bajwa; Jasleen Kaur
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-10

9.  Minimum effective volume of normal saline for epidural volume extension.

Authors:  Asha Tyagi; Surendra Kumar; Rashmi Salhotra; Ashok Kumar Sethi
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-04

10.  Continuous spinal analgesia with levobupivacaine for postoperative pain management: Comparison of 0.125% versus 0.0625% in elective total knee and hip replacement: A double-blind randomized study.

Authors:  Alessandro D'Ambrosio; Savino Spadaro; Chiara Natale; Antonella Cotoia; Michele Dambrosio; Gilda Cinnella
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.